- Home
- ALTI vs TSHA Comparison
ALTI vs TSHA Comparison
Compare ALTI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- TSHA
- Stock Information
- Founded
- ALTI 2020
- TSHA 2019
- Country
- ALTI United States
- TSHA United States
- Employees
- ALTI 430
- TSHA N/A
- Industry
- ALTI Investment Managers
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- ALTI Finance
- TSHA Health Care
- Exchange
- ALTI Nasdaq
- TSHA Nasdaq
- Market Cap
- ALTI 273.9M
- TSHA 356.7M
- IPO Year
- ALTI N/A
- TSHA 2020
- Fundamental
- Price
- ALTI $2.85
- TSHA $1.64
- Analyst Decision
- ALTI
- TSHA Strong Buy
- Analyst Count
- ALTI 0
- TSHA 8
- Target Price
- ALTI N/A
- TSHA $6.63
- AVG Volume (30 Days)
- ALTI 127.1K
- TSHA 1.5M
- Earning Date
- ALTI 03-13-2025
- TSHA 05-13-2025
- Dividend Yield
- ALTI N/A
- TSHA N/A
- EPS Growth
- ALTI N/A
- TSHA N/A
- EPS
- ALTI N/A
- TSHA N/A
- Revenue
- ALTI $206,935,000.00
- TSHA $8,333,000.00
- Revenue This Year
- ALTI $25.79
- TSHA N/A
- Revenue Next Year
- ALTI $9.88
- TSHA N/A
- P/E Ratio
- ALTI N/A
- TSHA N/A
- Revenue Growth
- ALTI N/A
- TSHA N/A
- 52 Week Low
- ALTI $2.33
- TSHA $1.19
- 52 Week High
- ALTI $6.36
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- ALTI 36.47
- TSHA 45.45
- Support Level
- ALTI $2.33
- TSHA $1.69
- Resistance Level
- ALTI $3.14
- TSHA $1.87
- Average True Range (ATR)
- ALTI 0.33
- TSHA 0.11
- MACD
- ALTI -0.02
- TSHA -0.00
- Stochastic Oscillator
- ALTI 39.69
- TSHA 23.33
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.